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Abstract 1 
Dietary habits have been strongly linked to the maintenance of intestinal epithelium homeostasis, 2 
whose alteration may contribute to the pathogenesis of inflammatory diseases and cancer. 3 
Polyphenols are among those dietary components suggested to be beneficial for gut health. Within a 4 
balanced Mediterranean type diet, a good portion of ingested polyphenols comes from olives and 5 
extra virgin olive oil (EVOO). Most of them reach the intestine, where they may be directly 6 
absorbed or metabolized under absorption. Others undergo an extensive gastrointestinal 7 
biotransformation, originating various metabolites that retain the potential beneficial effect of the 8 
parent compounds, or exert a more efficient biological action themselves. Ingested EVOO 9 
polyphenols (EVOOP) and their metabolites will be particularly concentrated in the intestinal 10 
lumen, where they might exert a significant local action. In this review we summarize the few 11 
studies that investigated the effect of EVOOP at intestinal level, focusing on the possible 12 
mechanism of action in relation to their interaction with the microbiota, and their ability to 13 
potentially modulate the oxidative status of the intestinal epithelial layer, inflammation and immune 14 
response.  15 
 16 
Abbreviation: extra virgin olive oil, EVOO; extra virgin olive oil polyphenols, EVOOP; 17 
hydroxytyrosol, HT; tyrosol, TYR; oleuropein, OL; homovanillic acid, HVA;  homovanillyl 18 
alcohol, HVAlc  19 
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1. Introduction 20 
The intestinal epithelium is a physical and biochemical barrier with a huge surface area, and defines 21 
the boundary between intestinal tissues and the external environment. The intestinal epithelium is 22 
specialized for nutrient and water absorption, and intestinal homeostasis depends on complex 23 
interactions among the intestinal epithelium, local and systemic immune factors, and the microbial 24 
content of the gut. 25 
A deregulation of this equilibrium may contribute to the pathogenesis of inflammatory diseases and 26 
cancer. Dietary components strongly influence intestinal epithelium homeostasis; the “western diet” 27 
has been associated to an elevated risk of developing intestinal diseases, as it alters intestinal 28 
microbiota, increases intestinal permeability and promotes inflammation. Other dietary components, 29 
as those characteristic of the Mediterranean diet, whole-grain foods, fruits, vegetables and derived 30 
products as wine and extra virgin olive oil (EVOO), have been proved to be beneficial for gut health 31 
1
. They are rich in bioactive compounds such as polyphenols, potentially able to exert antioxidant, 32 
anti-inflammatory and prebiotic effects at intestinal level 
2
. The average intake of polyphenols is 33 
approximately 1g/day 
3
. Most of them are poorly absorbed and directly or through the bile reach the 34 
colon, where they concentrate up to several hundred µM 
3
, in the parental form or partly 35 
metabolized. Thus, as suggested years ago by Halliwell 
4
, it is likely that in this site they exert a 36 
significant local action. Although the concentration of polyphenols is higher in the intestine than 37 
elsewhere, the number of studies that investigate their effect at intestinal level is quite limited.  38 
Even more limited are studies regarding specifically EVOOP. Only few human studies have 39 
evaluated the effect of EVOOP on the intestinal homeostasis; most have been performed on 40 
intestinal cell lines and on experimental colitis animal models. Therefore, there is limited in vivo 41 
evidence showing a beneficial effect of EVOOP in humans at intestinal level, and we may only 42 
speculate on a protective role based on what suggested by experimental models and observational 43 
trials.  44 
2. Extra virgin olive oil polyphenols 45 
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EVOO is obtained solely through physical means by mechanical or direct pressing of the olives. It 46 
is not subjected to any treatment except washing, decantation, centrifugation and filtration. The oil 47 
produced from this first press is known as EVOO; it is of the highest quality and it contains also the 48 
highest levels of beneficial constituents 
5-6
. The olive oil chemical composition consists of major 49 
components (triacylglycerol) that represent about 98-99% of the total oil weight, mainly oleic acid 50 
(MUFA) much higher (55-83%) than that of the other fatty acids (linoleic, palmitic, or stearic 51 
acids), which ranges between 3% and 21%. Minor components are present in small amounts (about 52 
2% of oil weight) and include more than 230 chemical compounds such as hydrocarbons 53 
(squalene), phytosterols (β-sitosterol, stigmasterol, and campersterol), tocopherols (α-tocopherol), 54 
carotenoids (β-carotene), coloring pigments (chlorophylls), aliphalic and triterpenic alcohols, 55 
volatile compounds and phenolics, such as tyrosol (TYR) and hydroxytyrosol (HT) 
7-9
.  56 
The phenolic fraction of EVOO is heterogeneous, with at least 36 structurally distinct phenolic 57 
compounds identified that can be grouped into the following classes:  58 
• Phenolic acids. They can be divided into three subgroups, hydroxybenzoic acids, such as, 59 
gallic, protocatechuic, and 4-hydroxybenzoic acids, hydroxycinnamic acids, such as caffeic, 60 
vanillin, syringic, p- coumaric, and o-coumaric acids and other phenolic acids and derivatives. 61 
These compounds are generally present in small amounts (<10 mg per kg of oil) 
10
. 62 
• Phenolic alcohols. These compounds possess a hydroxyl group attached to an aromatic 63 
hydrocarbon group, HT (3,4-dihydroxyphenyl-ethanol or 3,4-DHPEA,) and TYR (p-64 
hydroxyphenyl-ethanol or p-HPEA). Their concentration is usually low in fresh oils but increases 65 
during oil storage due to the hydrolysis of EVOO secoiridoids (ranging from 0 to 70 mg per Kg of 66 
oil) 
10-12
.  67 
• Secoiridoids. This phenolic group is characterized by the presence of either elenolic acid or 68 
elenolic acid derivatives in their molecular structure 
11, 13
. The most abundant are the dialdehydic 69 
form of decarboxymethyl elenolic acid linked to HT (3,4-DHPEA) or TYR (p-HPEA) (3,4-70 
DHPEA-EDA or p-HPEA-EDA), oleuropein (OL), its isomer, OL aglycon (HT linked to elenolic 71 
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acid) (3,4-DHPEA-EA), and ligstroside aglycon (TYR linked to elenolic acid) (p-HPEA-EA). p-72 
HPEA-derivates and dialdehydic forms of OL and ligstroside aglycon were also detected as minor 73 
hydrophilic phenols of EVOO 
14
. 74 
• Hydroxy-isocromans. This is a class of phenolic compounds recently characterized of 75 
EVOO and the presence of 1-phenyl-6,7- dihydroxy-isochroman and 1-(39-methoxy-49-hydroxy) 76 
phenyl-6, 7-dihydroxy- isochroman has been shown in several samples 
15
. 77 
• Flavonoids: These polyphenolic compounds contain two benzene rings joined by a linear 78 
three carbon chain and apigenine, luteoline, and (+)- taxifoline are the most concentrated. The 79 
amount of these compounds in EVOO is very low and generally ranges between 0 and 10 mg/kg of 80 
oil 
16
. 81 
• Lignans: The exact structure of this type of phenolic is not well understood but it is based on 82 
aromatic aldehydes condensation. (+)-1-pinoresinol, (+)-1-acetoxypinoresinol and 83 
hydroxypinoresinol were characterized as the most concentrated lignans in EVOO 
17
. These 84 
compounds are present in the pulp and in the woody portion of the seed 
18
. 85 
TYR, HT, and their secoiridoid derivatives make up around 90 % of the total phenolic content of 86 
EVOO 
19
. Not all phenolics are present in every EVOO and considerable variation has been noted 87 
in the concentration of such phenolic compounds (50 to 1000 mg/kg) 
5, 20-21
. 88 
The EVOO phenolic content is determined by several factors such as olive variety (cultivar), 89 
growing area, fruit ripening, cultivation techniques, processing and storage conditions 
22-24
.  90 
 91 
3. Metabolism and bioavailability  92 
The metabolic fate of phenolic compounds after ingestion has been the subject of several studies by 93 
the scientific community to find out the mechanisms through which they exert their activity into the 94 
organism. Indeed, bioavailability of EVOOP is the key in achieving an effect in specific tissues or 95 
organs 
25-26
. 96 
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Most of the studies regarding the bioavailability of these compounds have focused on the two most 97 
abundant EVOO simple phenolics: HT and TYR, amongst a few others 
27
. After ingestion, EVOOP 98 
can be partially modified in the acidic environment of the stomach. The effect of such environment 99 
on aglycone secoiridoids has been examined in vitro by incubating the compounds at 37 ºC in 100 
simulated gastric pH conditions (pH 2.0) and during normal physiological time frames (up to 4 h) 101 
28-29
. Although hydrolysis takes place releasing free phenolic alcohols, a significant amount remains 102 
intact and thus, enters the small intestine un-hydrolyzed. However, OL aglycone and its dialdehydic 103 
form, are likely not absorbed as such in the small intestine; in fact, the major metabolites detected 104 
using a perfused rat intestinal model were the glucuronide conjugates of the reduced form of both 105 
compounds 
29
. In contrast, if the ingested secoiridoid is glucosylated it appears not to be subjected 106 
to gastric hydrolysis 
30
, meaning that phenolics such as the glucosides of OL enter the small 107 
intestine unmodified, along with high amounts of free HT and TYR and remaining secoiridoid 108 
aglycones.  109 
Research evidence demonstrates that EVOOP are significantly absorbed (~40%–95%) in a dose-110 
dependent manner in humans 
30-37
 and  the major site for the absorption of these compounds is the 111 
small intestine 
30, 32, 38-40
.  112 
There are different mechanisms by which absorption occurs with regards to EVOOP. The different 113 
polarities of the various phenolics has been postulated to play a role in the absorption of these 114 
compounds 
30
. For instance, TYR and HT are polar compounds and their absorption has been 115 
shown to occur by a bidirectional passive diffusion mechanism across the membrane of the human 116 
enterocytes 
41
. Other EVOOP, such as p-coumaric acid, pinoresinol, luteolin 
25
 and HT acetate 
42
 117 
have shown  the same mechanism of transport.  118 
Larger compounds may be absorbed via a different mechanism to TYR and HT. It has been 119 
proposed that the polar but larger OL-glycoside may diffuse through the lipid bilayer of the 120 
epithelial cell membrane and be absorbed via a glucose transporter, but, potentially also via the 121 
paracellular route or transcellular passive diffusion 
43
. Despite being well absorbed, the 122 
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bioavailability of EVOOP is scarce due to an extensive pre-systemic first-pass metabolism in the 123 
gut and liver 
27
. 124 
Once absorbed, EVOOP are, in fact, subjected to three main types of conjugation: methylation, 125 
glucuronidation and sulfation, through the respective action of catechol-O-methyl transferases 126 
(COMT), uridine-5’-diphosphate glucuronosyltransferases (UDPGT) and sulfotransferases (SULT) 127 
44
.  128 
Different studies showed that HT and TYR can be metabolized to O-glucuronidated conjugates  
31, 
129 
33, 40, 45-46
, but HT also undergoes O-methylation, and both homovanillic acid (HVA) and 130 
homovanillyl alcohol (HVAlc) have been detected in human and animal plasma and urine after oral 131 
administration of either EVOO or pure HT and TYR 
34, 40, 47-49
. 132 
The urinary excretion of HVAlc and HVA in humans was reported for the first time by Caruso et al. 133 
45
 after the intake of different EVOOs (the lowest administered dose was 7 mg of total HT/50 mL 134 
oil, and the max provided about 23 mg/50 mL oil). HVAlc contributes to 22% of the total excretion 135 
of HT and its metabolites, and HVA 56%. The excretion of both metabolites correlated with the 136 
administered dose of HT. Even at low doses, HVAlc and HVA were excreted. In a later study, 137 
Miró-Casas et al. 
39
 observed how urinary amounts of HT and HVAlc increased in response to 138 
EVOO ingestion, reaching the maximum peak at 0-2 h. Urinary recovery 12 h after olive oil 139 
ingestion showed that 65% of HT was in its glucuronoconjugated form and 35% in other conjugated 140 
forms.  141 
Urinary concentrations and excretion rates of glucuronides of EVOOP were also successfully 142 
estimated in a study carried out by Khymenets et al. 
46
, using a dietary dose of EVOO (50 mL). 143 
About 13% of the consumed EVOOP were recovered in 24-h urine, where 75% of them were in the 144 
form of glucuronides (30- and 40-O-HT glucuronides, 40-O-glucuronides of TYR) and 25% as free 145 
compounds. 146 
A study conducted by Corona et al. 
28
 about absorption, metabolism and microflora-dependent 147 
transformation of HT, TYR and their conjugated forms (e.g. OL) also showed similar results; both 148 
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HT and TYR, transferred across human Caco-2 cell monolayers and rat segments of jejunum and 149 
ileum, were subject to classic phase I/II biotransformation. The major gastrointestinal metabolites 150 
identified were an O-methylated derivative of HT, glucuronides of HT and TYR and a novel 151 
glutathionylated conjugate of HT (HT-GSH). In contrast, there was no absorption of OL in either 152 
model 
28
. 153 
On the other hand, sulfation can occur after gastrointestinal absorption, in fact in different studies 154 
conducted testing phenol-enriched virgin olive oils 
37, 50-51
, sulfation was the main conjugation 155 
pathway for EVOOP, whereas the glucuronidated forms were not detected. The main phenolic 156 
metabolites detected in plasma samples after ingestion of EVOO were, HT sulfate, HT acetate 157 
sulfate, HVA and HVA sulfate. HT sulfate appears to be a good biomarker for monitoring 158 
compliance of EVOO intake and a very recent study using pure HT 
52
 seems to reinforce this 159 
notion. In this last study, quantitatively, the total amount of HT recovered in the urine was minimal 160 
and accounted for 0.02% (only for the 25 mg dose). For the metabolites, they observed a dose-161 
dependent increase in their excretion. And the major metabolite detected was HT 3-sulphate, which 162 
accounted for 23.1% (for the 5 mg dose) and 16.6% (for the 25 mg dose) of the administered HT, 163 
followed by HT 3-O-glucuronide with 2.78% (for the 5 mg dose) and 2.87% (for the 25 mg dose). 164 
Suárez et al. 
53
 considered for the first time the absorption and disposition of flavonoids and lignans 165 
after the ingestion of EVOO. Besides the presence of those EVOOP in their conjugated forms, an 166 
important variability in the concentrations was observed between the plasma samples obtained from 167 
different volunteers. This variability may be attributed to differences in the expression of 168 
metabolizing enzymes due to genetic variability within the population 
53
.  169 
Also De Bock et al. noted a large inter-individual variation in absorption and metabolism of 170 
phenolic compounds in a study with olive leaf extracts administration in humans, possibly resulting 171 
from differences in human enzymatic activity. For example, males may be more efficient at 172 
conjugating OL, which would explain their lower area under the curve (AUC) for OL but higher 173 
AUC for HT metabolites 
54
. 174 
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The most comprehensive study regarding the identification of metabolites in human urine of most 175 
of the EVOOP (i.e. secoiridoids, flavanoids and phenolic alcohols) was reported by García-Villalba 176 
et al. 
55
. These authors were able to achieve the tentative identification of 60 metabolites. Phenolic 177 
compounds were subjected to various phase I and phase II reactions, mainly methylation and 178 
glucuronidation. For instance, the largest number of metabolites was produced from HT, OL 179 
aglycone and oleocanthal, indicating significant post-absorption metabolism of these compounds. 180 
Conversely, the lowest number of metabolites came from TYR, luteolin, apigenin, pinoresinol and 181 
acetoxypinoresinol, suggesting that these compounds may have been excreted in faeces, destroyed 182 
in the gastrointestinal tract, excreted through another metabolic pathway or poorly absorbed 
55
. A 183 
recent paper by De la Torre et al. further confirmed the presence of HT and its major methylated 184 
metabolite, 3-O-methyl-hydroxytyrosol or HVAlc, in urine following EVOO consumption in a high 185 
risk of CVD subjects, where HVAlc concentration was predictive of CVD 
56
.  186 
In the case of poorly absorbed phenolic compounds, it has been suggested that these components 187 
may exert a local protective action in the large intestine, and this assumption is supported by 188 
research demonstrating, for instance, the free radical scavenging capacity of EVOOP in both the 189 
faecal matrix and intestinal epithelial cells 
19
.  190 
4. Interaction with the microbiota 191 
EVOOP can likely influence the gut microbial balance since, as reviewed in the previous paragraph, 192 
most of them are not completely absorbed into the upper parts of the gastrointestinal tract and reach 193 
the colon, where the different microbial species that inhabits the intestine reach the highest 194 
concentration 
57
. The complex interaction between dietary polyphenols and the microbiota has been 195 
extensively studied, being recognized as one of the factor contributing to the beneficial effect of 196 
polyphenols consumption, although the mechanisms are still poorly understood. 197 
Colon bacteria substantially contribute to the biotransformation of the polyphenols, breaking down  198 
unabsorbed compounds into a wide range of metabolites, which may be absorbed or excreted. 199 
Bacteria may also further modify enterocytes-derived metabolites 
58
. On the other hand, dietary 200 
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polyphenols and their metabolites may strongly influence microbiota composition, inhibiting the 201 
growth of harmful bacteria and exerting prebiotic-like effects towards beneficial bacteria, as nicely 202 
reviewed by Cardona et al. 
58
.  203 
However, studies specifically regarding the impact of dietary intake of olives or EVOO polyphenols 204 
on the microbiota are scarce. One of the first studies on the biotransformation of ingested EVOOP 205 
by colonic microflora, was the in vitro study conducted by Corona et al.
28
 cited above. The authors, 206 
using human fecal microbiota and a perfused rat intestinal model, demonstrated that these phenolic 207 
compounds undergo an extensive metabolisation in the passage through the gastrointestinal tract 208 
and are mainly absorbed as simple phenols in the small intestine. However, OL reaches the large 209 
intestine as an unmodified compounds and it is rapidly degraded in this site by the microflora to 210 
yield mainly HT. Using the same in vitro experimental model, Mosele et al. 
59
 reported HT as the 211 
main product of OL microbial metabolisation, together with a pool of phenolic acids resulting from 212 
further metabolisation. HT, HT acetate and TYR, tested as individual phenols, also originated 213 
phenolic acids, as phenylacetic acid, phenylpropionic acid and their hydroxylated derivatives.     214 
A subsequent study determined in rat feces, after oral administration of OL, the presence of the 215 
parent compound together with other metabolites, identified as HT, elenolic acid and HVA 
60
. In 216 
human fecal samples, obtained before and after the sustained intake of a phenol-enriched olive oil, 217 
free HT, phenylacetic acid, 2-(4’-hydroxyphenyl)acetic acid, 2-(3’-hydroxyphenyl)-acetic acid, 3-218 
(4’-hydroxyphenyl)-propionic acid were detected; neither OL nor HVA were present in human 219 
feces, probably because of the differences in the gut metabolic responses between rat and human 
59
.  220 
Microbial-derived phenolic acids have been reported to exert a significant biological activity at 221 
local and systemic level 
61
; phenylacetic and phenylpropionic acids, together with their variously 222 
hydroxylated derivatives, are among the predominant structures in fecal water 
62
 and have shown to 223 
inhibit platelet aggregation 
63
 and the growth of intestinal pathogenic bacteria 
64
. 224 
OL is likely to be preferentially degraded in vivo by lactic acid bacteria, as Lactobacillus and 225 
Bifidobacterium species 
65
, which are involved in developing the spontaneous or started lactic 226 
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fermentation of table olives but also contribute, as probiotic bacteria, to maintain or improve 227 
microbial balance in the gut 
66
. Thanks to the β-glucosidase and esterase activity 
67
, L. plantarum, 228 
that is also found as natural inhabitant of the human gastrointestinal tract, is the most effective 229 
bacteria converting OL into HT 
65, 68
 and it is also able to metabolize some phenolic acids as 230 
protocatechuic acid 
69
, ferulic, gallic and coumaric acids through inducible decarbossilase and 231 
reductase enzymes (
70
 and references therein). Thus, OL possess prebiotic properties, as 232 
Lactobacillus and Bifidobacterium strains may utilize it as a carbon source, but others such as 233 
Clostridium and E. coli cannot 
28
. Actually, it is assumed that EVOOP might influence the 234 
composition of the microbiota also inhibiting the growth of pathogenic bacteria. The antimicrobial 235 
activity of phenolic compounds from Olea europaea has been extensively studied since the early 236 
1970s, although, depending on the experimental conditions, results have been contrasting. HT, for 237 
example, has been shown to inhibit E. coli growth 
71
, although culture media and the type of strain 238 
remarkably affected the bacterial susceptibility to HT 
72
. HT exhibited also a significant 239 
antimicrobial activity against selected Enterobacter species 
73
. Similarly, OL was effective in  E. 240 
coli growth inhibition 
74
. In general, several experimental trials showed OL and HT to be the best 241 
inhibitors of several gastrointestinal pathogens, as reported in the recent review of Thielmann et al. 242 
75
. However, this great amount of data arises from in vitro experiments that do not mimic the in vivo 243 
conditions. To the best of our knowledge, there are only two recent reports by Martin-Pelaez et al. 244 
76-77
 and one from Conterno et al.
78
 on the modulation of microbiota by EVOOP in humans. Martin-245 
Pelaez’s studies arise from the VOHF study, a randomized, controlled, double-blind, crossover 246 
clinical trial with hypercholesterolemic subjects 
79
. In a subsample of 12 hypercholesterolemic 247 
adults 
76
, changes in faecal microbial populations were evaluated following sustained consumption 248 
of EVOOP, alone or in combination with thyme polyphenols; the study reported a slight HT 249 
modification in microbial composition following EVOOP intake, depending on the dosage, as 250 
confirmed by the parallel study in another subsample of 10 subjects 
77
. A significant increase of 251 
Bifidobacterium group numbers was detected instead, when polyphenols from olive oil and thyme 252 
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were ingested in combination 
76
. Among the microbial phenolic metabolites, dihydroxyphenyl and 253 
hydroxyphenyl acetic acid, and a significant amount of protocatechuic acid and HT were detected in 254 
faeces after dietary interventions with polyphenols. The ingestion of a mixture of olive oil and 255 
thyme polyphenols exerted a cardio-protective effect in hypercholesterolemic subjects, mediated by 256 
the specific growth stimulation of Bifidobacteria, together with the increases in microbial phenolic 257 
metabolites with antioxidant activities such as protocatechuic acid and HT 
76
. Conterno et al. 258 
reported small changes within the composition of the gut microbiota, showing a small increase in 259 
Bifidobacteria, and an up-regulation of microbial polyphenol biotransformation in the intestine, 260 
following ingestion of olive pomace extract-enriched biscuits.
78
  261 
Although the complex interrelation between EVOOP and human microbiota is still far from being 262 
exhaustively investigated, data collected so far clearly suggest a concentration dependent impact of 263 
phenolic compounds and metabolites on bacterial growth and on the associated metabolic 264 
consequences at local and systemic level.    265 
 266 
5. Antioxidant and anti-inflammatory effect at intestinal level 267 
Dietary polyphenols have been claimed to exert both a protective and therapeutic effect in the 268 
management of gastro intestinal disorders, mainly those strictly linked to oxidative stress and 269 
chronic inflammation, as IBD. Being particularly concentrated in the intestinal tract, dietary 270 
polyphenols, now undoubtedly associated with scientifically validated antioxidant and anti-271 
inflammatory properties, may act locally reducing oxidative stress and inflammatory response 
2, 80
.  272 
5.1 Antioxidant effect 273 
The gut lumen is likely to be the only site where EVOOP, together with their active metabolites, 274 
may reach a concentration high enough to enable them to act as direct antioxidants, scavenging 275 
ROS; once absorbed, they may also modulate the expression of genes linked to antioxidant cellular 276 
defenses via molecular targets. The phenolic fraction of EVOO has been shown to protect intestinal 277 
Caco-2 cells against the alteration of cellular redox status and oxidative damage to the membrane 278 
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lipid fraction, due to the pro-oxidant action of oxidized lipids and this effect has been correlated to 279 
the activity of the most abundant phenolic compounds present in the tested fraction, HT, TYR and 280 
OL 
81
. As reviewed in the first paragraph, HT, TYR and OL, together with their metabolites, are the 281 
major phenols found at intestinal level, following ingestion of EVOO, and, due to their high local 282 
concentrations, they might exert a relevant antioxidant effect. HT has been recognized as the most 283 
efficient free radical scavenger and radical chain breaker, and its catecholic structure is also able to 284 
prevent reactive species formation through metal chelation features 
82-83
. It has been shown to 285 
protect Caco-2 cells against oxidative injury 
84-86
, because of its scavenging properties, and its major 286 
metabolites, sulfates and glucuronides, showed an efficiency in protecting Caco-2 cells 
87
, as well as 287 
renal cells 
88
 and erythrocytes 
89
, comparable or even better than that of the parent compound. TYR 288 
has also been shown to be effective in protecting Caco-2 cells against the cytostatic and cytotoxic 289 
effects produced by oxidized LDL 
90
 and to possess scavenging effects on peroxyl radicals 
84, 91
, O2
−
 290 
92
 and ONOO
− 93
. Although there are no studies regarding specifically the intestinal compartment, 291 
trials in animal models and cell cultures demonstrated that HT is able to increase the endogenous 292 
defense system, through the modulation of related gene expression.  293 
In human HepG2 cells HT enhanced the expression and the activity of the glutathione related 294 
enzymes, glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione S-transferase 295 
(GST) 
94
. The modulating activity of HT on the glutathione antioxidant network has been also 296 
demonstrated in the adipose tissue of mice fed an HT-supplemented diet 
95
 and in the liver of obese 297 
mice after 17 weeks supplementation 
96
. HT has been shown to be a potent inducer of phase II 298 
detoxifying enzymes in retinal pigment epithelial cells 
97
 and to increase the expression and activity 299 
of SOD and CAT in rats fed a cholesterol-rich diet 
98
. The effect of HT on the cellular antioxidant 300 
enzymes has been linked to its ability to increase the translocation of Nrf2 
94, 97
 to the nucleus, thus 301 
promoting the expression of genes related to the antioxidant defense system and contributing to the 302 
protection of cells against oxidative stress. However, this hypothesis has never been proven in 303 
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humans; indeed, a pilot study on humans demonstrated that HT administration did not significantly 304 
modify phase II enzyme expression in peripheral blood mononuclear cells 
99
.   305 
Recent studies showed the ability of TYR and its sulfate metabolite to induce the GPx activity in 306 
Caco-2 cells 
87
 and, together with its glucuronide metabolite, to restore GSH level and related 307 
antioxidant enzymes in TNF-α treated human endothelial cells 
100
, as previously demonstrated in 308 
macrophages, where TYR preserved cellular antioxidant defenses against the pro-oxidant effect of 309 
oxidized  LDL 
101
. In a mouse model of lipopolysaccharide (LPS)-induced acute lung injury, TYR 310 
pretreatment attenuated the inflammatory response and improved expression of the antioxidant 311 
enzymes, through the activation of Nrf2  
102
. 312 
OL possesses well-documented pharmacological properties, including a potent antioxidant activity 313 
mainly due to the presence of hydroxyl groups in its chemical structure. Its free radical scavenging 314 
and metal-chelating activities enable OL to inhibit the production of a wide range of ROS and RNS 315 
in in vitro cell-free systems, as well as in cultured cells, as reported in the Hassen et al. extensive 316 
review 
103
. There are also evidence for the stimulatory effect of OL on the expression of the 317 
intracellular antioxidant enzymes in free endothelial progenitor cells, via the activation of Nrf2 
104
, 318 
and in normal human liver cells 
105
. In vivo data confirm the ability of OL to increase the level and 319 
activities of enzymatic antioxidants in rats fed a cholesterol rich diet 
106
, in acute arsenic exposed 320 
rats 
107
, in the hypothalamus of hypertensive rats 
108
, in the substantia nigra of aged rats 
109
 and to 321 
enhance the level of non enzymatic antioxidants such as glutathione, α-tocopherol, ascorbic acid 322 
and β-carotene in alloxan-diabetic rabbits 
110
.   323 
5.2  Anti-inflammatory effect 324 
A large body of studies carried out in cell cultures, animal models and humans provides solid 325 
evidence that EVOOP are able to inhibit the inflammatory process, through the modulation of 326 
different signaling pathways regulating immune cells response, activation of pro-inflammatory 327 
enzymes and release of inflammatory mediators 
111
.   328 
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There are few studies focusing on the anti-inflammatory action of EVOOP at intestinal level. In 329 
cultured Caco-2 cells stimulated with LPS or IL-1β, EVOOP are able to regulate IL-8 expression by 330 
transcriptional or posttranscriptional mechanisms, depending on the stage of inflammation 
112
. We 331 
recently demonstrated that EVOOP may also counteract oxysterols-induced redox imbalance and 332 
pro-inflammatory response in Caco-2 cells, inhibiting cytokines and NO release, through the 333 
modulation of the MAPK-NF-kB pathway 
113
. 334 
Studies in animal models show that an EVOO diet enriched with phenolic compounds mitigate the 335 
severity of DSS-induced colitis in mice, attenuating clinical and histological signs of damage of 336 
colonic segments, suppressing oxidative events and inhibiting pro-inflammatory protein expression 337 
114-116
.  338 
The anti-inflammatory activity of the phenolic fraction is likely to be dependent on the active 339 
constituents OL, HT and oleocanthal, whose anti-inflammatory effect has been clearly 340 
demonstrated in vitro. In the same mice model of DSS-induced colitis, oral administration of OL 341 
attenuated the extent and severity of acute colitis, reducing pro-inflammatory cytokine, IL-1β, IL-6, 342 
TNF-α and NO production and enhancing anti-inflammatory cytokine levels, IL-10, in the colonic 343 
tissue. The molecular mechanism of its protective action seems at least in part linked to the down-344 
regulation of COX-2 and iNOS proteins gene expression and to the up-regulation of annexin A1, 345 
which may mediate the suppression of p38 MAPK phosphorylation and NF-κB translocation to the 346 
nucleus 
116-117
. A subsequent investigation by the same group confirmed the ability of OL to 347 
modulate intestinal immune response in DSS acute model, inhibiting Th17 response and the release 348 
of Th17-related cytokines, and, down regulating inflammatory mediators, to inhibit the 349 
development of the connected colorectal cancer 
118
. 350 
A recent study conducted in colonic biopsies obtained from patients with ulcerative colitis 351 
demonstrated the ability of OL to ameliorate the inflammatory damage and reduce infiltration of 352 
CD3, CD4, and CD20 cells, while increasing CD68 numbers. In the colonic biopsies treated with 353 
Page 15 of 33 Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 Ju
ly
 2
01
8.
 D
ow
nl
oa
de
d 
by
 U
N
IV
 D
EG
LI
 S
TU
D
I D
I C
A
G
LI
A
RI
 o
n 
7/
27
/2
01
8 
2:
36
:1
9 
PM
. 
View Article Online
DOI: 10.1039/C8FO00354H
16 
 
LPS and OL the expression of COX-2 and IL-17 were significantly lower compared with those 354 
treated with LPS alone 
119
.  355 
HT also demonstrated an anti-inflammatory effect in vivo, when locally applied in TNBS-induced 356 
colitic rats 
120
, and when administered within HT supplemented EVOO-diet to DSS-induced colitic 357 
mice. This anti-inflammatory effect has been related to the ability to modulate cytokines secretion 358 
and to reduce COX-2 and iNOS expression in colonic mucosa, by down regulating p38 MAPK 359 
pathway 
121
. These observations agree with the study of Corona et al.
122
 in Caco-2 cells which 360 
demonstrates that inhibition of p38 significantly reduces COX-2 expression. 361 
A significant beneficial effect in chronic DSS-induced colitis was also exerted by HT acetate, 362 
sharing the same mechanism of action as HT 
123
. There is strong evidence in vitro that also 363 
oleocanthal is an effective anti-inflammatory agent. In fact, it can efficiently inhibit COX-2 enzyme 364 
expression and activity, which is implicated in the pathogenesis of several cancers 
124
.  365 
The findings of these few studies suggest that EVOOP have the potential to exert anti-inflammatory 366 
effects in the human gastrointestinal mucosa, however, no human studies, up to now, have 367 
specifically dealt with this issue. 368 
 369 
6. Anti-carcinogenic effect at intestinal level 370 
Over the past decades, epidemiological studies have indicated an inverse correlation between 371 
EVOO consumption and the incidence of different type of cancers, although the scientific evidence 372 
in support of this correlation is still limited 
125
. It has been shown that the Mediterranean diet, and 373 
EVOO seem to be protective against colon cancer 
126-127
. A systematic review and meta-analysis 374 
analyzed 19 case-control studies (13800 cancer patients and 23340 controls) and found that high 375 
olive oil consumption was associated with lower odds of having any type of cancer 
128
. Moreover, 376 
high olive oil consumption was associated with lower odds of developing breast cancer (logOR = -377 
0,45 95% CI -0.78 to -0.12), and a cancer of the digestive system (logOR = -0,36 95% CI -0.50 to -378 
0.21), compared with the lowest intake 
128
. In addition, another systematic review and meta-analysis 379 
Page 16 of 33Food & Function
Fo
od
&
Fu
nc
tio
n
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 Ju
ly
 2
01
8.
 D
ow
nl
oa
de
d 
by
 U
N
IV
 D
EG
LI
 S
TU
D
I D
I C
A
G
LI
A
RI
 o
n 
7/
27
/2
01
8 
2:
36
:1
9 
PM
. 
View Article Online
DOI: 10.1039/C8FO00354H
17 
 
included 25 studies, and concluded that high olive oil consumption decreased the risk of upper 380 
digestive and respiratory tract neoplasms, breast and, possibly, colorectal and other cancer sites 
125
. 381 
More recently, a systematic review reported the association between EVOOP and other 382 
Mediterranean diet components with a reduction of colorectal cancer initiation, promotion and 383 
progression 
129
. Several nutrients play a significant role in colorectal cancer development, and the 384 
importance of monounsaturated fatty acids has been highlighted 
130
. 385 
In addition, EVOOP, including phenolic alcohols, lignans and secoiridoids, are thought to be, in 386 
part, responsible for EVOO reported anti-carcinogenic effects 
131
. EVOOP have been shown to 387 
influence carcinogenesis and tumor development at various levels 
132-134
: by exerting antioxidant 388 
activities 
135-136
, by modulating detoxification enzyme systems 
137
, and the immune system 
138
,  by 389 
reacting with activated carcinogens and mutagens 
139-140
, and by exerting actions on proteins 390 
controlling cell cycle progression  
122, 141-142
, and gene expression 
143-144
.  391 
The ability of EVOO to inhibit colon cancer development has been demonstrated in large intestinal 392 
cancer cell models 
122, 144-145
, in animals 
140, 146
 and in humans 
131, 147
. In experimental models, olive 393 
oil consumption has been shown to prevent benzo(a)pyrene [B(a)P]-induced colon carcinogenesis 394 
in Apc(Min) mice 
140
, reduce the incidence of aberrant crypt foci in azoxymethane-treated rats 
146
 395 
and dimethyl-benz(a)antracene-induced mammary carcinogenesis 
148
, and has been shown to induce 396 
significant levels of apoptosis in large intestinal cancer cells 
136, 145
. In animal models, n9 fatty acids 397 
present in olive oil have been able to prevent the development of aberrant crypt foci and colon 398 
carcinomas 
146
. Thus, EVOOP have also been shown to play an important role, due to their ability to 399 
inhibit the initiation, promotion and metastasis of the carcinogenetic process in human colon 400 
adenocarcinoma cells 
149-150
.  Furthermore, EVOO has been shown to down-regulate the expression 401 
of COX-2 and Bcl-2 proteins that have a crucial role in colorectal carcinogenesis 
145
.   402 
A study conducted using different colon cancer cell lines (p53 proficient, mutant and knocked out), 403 
demonstrated that a pinoresinol-rich olive oil extract was capable of reducing cancer cell viability 404 
(particularly in p53-proficient cells), inducing apoptosis, inducing a G2/M cell cycle block and 405 
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causing the up-regulating of ATM and a parallel decrease of cyclin B/cdc2 
151
. Similar experiments 406 
conducted with purified pinoresinol resulted in similar effects, although higher concentrations were 407 
required, indicating a possible synergistic effect between pinoresinol and other polyphenols in 408 
EVOO 
151
.   409 
The cellular mechanism by which EVOOP exert anticancer effects can also be linked to the 410 
modulation of MAPK kinases and COX-2 
122
. COX-2 is over-expressed in colorectal cancer, and its 411 
over-expression has a strong association with colorectal neoplasia, by promoting cell survival, cell 412 
growth, migration, invasion and angiogenesis 
152
. An efficient inhibitor of COX-2, oleocanthal, 413 
repressed cell viability and induced apoptosis in human colon carcinoma HT-29 cells, via AMPK 414 
activation and COX-2 suppression 
153
, and it has also been proven to reduce proliferation and 415 
migration in different cancer cells, deactivating the activity of various mediators in addition to 416 
COX-2, which result in tumorogenesis 
124
.  417 
The MAPK signaling pathway has long been viewed as an attractive pathway for anticancer 418 
therapies, based on its central role in regulating the growth and survival of cells from a broad 419 
spectrum of human cancers 
154
, and it also modulates the transcriptional and post-transcriptional 420 
activation of COX-2 
155
.  421 
An EVOO phenolic extract has been shown to exert a strong inhibitory effect on the growth of 422 
colon adenocarcinoma cells through the inhibition of p38/CREB signaling, a decrease in COX-2 423 
expression and the stimulation of a G2/M phase cell cycle block 
122
. In contrast, HT exerts its anti-424 
proliferative effects via its ability to strongly inhibit ERK1/2 phosphorylation and downstream 425 
cyclin D1 expression 
142
. These findings are of particular relevance due to the high colonic 426 
bioavailability of HT compared to the other EVOOP and may help explain the inverse link between 427 
colon cancer and EVOO consumption. 428 
Furthermore, HT inhibits colon cancer cell proliferation 
156
 and induces cancer cell apoptosis 
157
 429 
through a mechanism of action linked to a prolonged stress of the endoplasmic reticulum (activation 430 
of unfolded proteins) and over-expression of pro-apoptotic factors, such as Ser/thr phosphatase 2A, 431 
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a key protein involved in the induction of apoptosis in colon cancer cells 
157
. TYR on the other 432 
hand, has been found to reverse a number of effects induced by oxidized lipids, including ROS 433 
overproduction, GSH depletion, the impairment in antioxidant enzyme activity and the increase in 434 
the expression of p66Shc protein 
101, 158-159
. All of these findings suggest that the ability of EVOOP 435 
as intestinal anti-cancer agents should be reappraised, as it is clear that their actions on the process 436 
of carcinogenesis are many-fold and involve more than simple antioxidant effect. 437 
 438 
7. Conclusions 439 
A large body of evidence suggests the potential for EVOOP to promote beneficial health effects in 440 
the prevention and amelioration of several chronic diseases, mainly cardiovascular diseases, 441 
neurodegenerative disorders and cancer, as recently outlined by Visioli et al., who critically 442 
summarized the main reported findings on the effects of EVOO consumption on human health, 443 
discussed in the last International Olive Council Conference 
160
. Studies on the absorption and 444 
metabolization of EVOOP show that some complex polyphenols reach the intestine, where they 445 
may be directly absorbed or metabolized during absorption, while others undergo an extensive 446 
gastrointestinal biotransformation. Therefore,  a significant amount of bioactive compounds, mainly 447 
simple phenols and metabolites, will be present in the small and large intestine, concentrating at this 448 
site.  449 
Considering that dietary intake of EVOOP in the Mediterranean area has been estimated to be 450 
around 9 mg, based on 25 - 50 ml of EVOO daily consumption 
19
, EVOOP may significantly 451 
contribute to preserve intestinal epithelium homeostasis. As suggested by the few studies 452 
summarized in this review (Table 1), EVOOP may help to counteract oxidative stress and can 453 
modulate intestinal inflammation, gut microbiota and immune response, thus helping to prevent the 454 
onset or delay the progression of inflammatory/degenerative diseases. Although more studies are 455 
necessary to validate the important role of EVOOP in the maintenance of intestinal homeostasis, the 456 
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regular consumption of EVOO should be highly promoted also in view of their possible role in 457 
preventing intestinal diseases. 458 
 459 
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Table 1. Overview of EVOOP actions at intestinal level     
Compound  Experimental system Mechanism  Ref. 
Interaction with microbiota 
  
 
OL, HT, TYR in vitro batch colonic 
fermentation/ 
perfused rat intestinal model 
increase of bioactive phenolic metabolites 28 
TYR, HT, HT acetate and 
OL/phenols-enriched OO 
in vitro batch colonic 
fermentation/ 
human intervention study 
increase of bioactive phenolic metabolites in 
faeces 
59 
OL oral administration in rats increase of bioactive phenolic metabolites in 
faeces 
60 
HT,TYR broth dilution  growth inhibition of E. coli (ATCC no. 25922) 71 
HT broth dilution  growth inhibition of E. coli (CECT 533, 4972, 
and 679 grown in LB and E. coli 4972 grown 
in ISO) 
72 
HT agar plates growth inhibition of E. coli, Enterobacter and  
Enterococcus species 
73 
OL, HT/ phenolic extract broth dilution  growth inhibition of E. coli (C7085L) 74 
phenols-enriched OO/ 
phenols and thyme phenols-
enriched OO 
double-blind, cros-sover human 
trial 
increase of Bifidobacteria 
increase of bioactive phenolic metabolites in 
faeces 
76 
77 
olive pomace enriched 
biscuits 
double-blind, parallel dietary 
intervention in human subjects 
increase of Bifidobacteria 78 
Antioxidant effect    
HT, TYR, homovanillic 
alcohol 
TBH treated human colon  
adenocarcinoma cells (Caco-2) 
inhibition of oxidative modification of  
membrane lipid fraction 
84 
HT H2O2 or xanthine 
oxidase/xanthine 
treated Caco-2 cells 
inhibition of lipid peroxidation and monolayer  
permeability changes 
85 
HT acrylamide treated Caco-2 cells prevention of ROS overproduction  86 
HT, TYR and sulfate 
metabolites 
oxydized cholesterol treated  
Caco-2 cells 
inhibition of ROS and MDA production 
 and GSH depletion 
87 
TYR oxidized LDL treated Caco-2 
cells 
inhibition of morphological and functional 
alterations 
90 
phenolic extract oxysterols treated Caco-2 cells reduction of ROS production and GSH 
depletion 
113 
Anti-inflammatory effect    
phenolic extract LPS or IL-1β treated Caco-2 cells prevention of IL-8 expression and secretion,  
regulation of IL-8 mRNA transcription and 
stability 
112 
phenolic extract oxysterols treated Caco-2 cells inhibition of IL-6, IL-8 and NO release,  
modulation of MAPK-NF-kB pathway 
113 
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phenols-enriched EVOO DSS-induced chronic colitis in 
mice 
attenuated damage of colonic segments,  
 PPARγ up-regulation, NF-kB, MAPK  
and downstream inflammatory cascade 
inhibition 
114 
EVOO unsaponifiable 
fraction 
DSS-induced acute colitis in mice attenuated damage of colonic segments, 
decreased MCP-1 and TNF-α levels, iNOS 
and COX-2 overexpression and p38 MAPK 
activation 
115 
OL DSS-induced acute colitis in mice reduction of neutrophil infiltration,  NO, IL-
1β,  
IL-6, and TNF-α production, iNOS, COX-2,  
and MMP-9 expression 
116 
OL DSS-induced chronic colitis in 
mice 
attenuated colon damage,  
reduction of COX-2 and iNOS expression and 
IL-1β  
and IL-6 release; increase of IL-10 
117 
OL DSS-induced acute colitis in mice inhibition of Th17 response and Th17-related 
cytokines release 
118 
OL LPS treated colonic biopsies  
from UC patients 
reduced expression of COX-2, IL-17 and  
infiltration of CD3,CD4 and CD20 cells 
119 
HT TNBS- induced colitis in rats reduced inflammatory infiltration 120 
HT-enriched EVOO DSS-induced chronic colitis in 
mice 
attenuated colon damage,  
reduced TNF-α, COX-2 and iNOS expression,  
downregulation of p38 MAPK; increase of 
IL10  
121 
HT acetate DSS-induced acute colitis in mice improved histological damage, reduction of 
COX-2  
and iNOS expression, inhibition of JNK 
MAPK and NF-kB  
123 
Anti-carcinogenic effect    
 phenolic extract CaCo-2 cells inhibition of cell proliferation, induction of  
G2/M phase cell cycle block, inhibition of p38 
and CREB activation, reduction in COX-2 
expression. 
122 
HT adenocarcinoma cells (DLD1 
cells) 
ROS generation, apoptotic cell death, 
mitochondrial dysfunction, phosphoinositide 
3-kinase/Akt pathway activation, FOXO3a 
phosphorylation, FOXO3a's target genes 
downregulation.  
136 
HT CaCo-2 cells inhibition of cell proliferation, induction of  
G2/M phase cell cycle block, inhibition of 
ERK1/2 activation,  reduction of cyclin D1 
expression. 
142 
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EVOO, phenolic extract, HT CaCo-2 cells, rat colon up-regulation of CNR1 gene in CaCo-2 cells, 
reduced DNA methylation at CNR1 promoter 
in CaCo-2 cells, reduced cell proliferation; 
increase in CB(1) expression in rat colon, 
reduction of CpG methylation of rat Cnr1 
promoter, miR23a and miR-301a 
144 
phenolic extract colon cancer cells (HT-29), 
intestinal barrier function (CaCo-
2 cell monolayers), matrigel 
invasion assay (HT115 cells) 
reduction of DNA damage (HT-29), improved 
barrier function (CaCo-2), inhibition of 
HT115 invasion, inhibition of HT115 cell 
attachment 
149 
phenolic extract, HT, TYR, 
pinoresinol, caffeic acid 
Matrigel invasion assay (HT115 
cells) 
anti-invasive effects, no citotocixity observed, 
no effects on cell attachment 
150 
pinoresinol-rich phenolic 
extract, oleocanthal-ric 
phenolic extract 
 p53 proficient (RKO and 
HCT116 ), and p53 knocked out 
(SW480 and HCT116 p53-/-) cell 
lines 
reduction of cell viability,increased apoptosis,  
cell cycle  arrest at G(2)/M, up-regulation of 
ATM signalling pathway, decrease of cyclin 
B/cdc2 
151 
HT HT-29 inhibition of cell proliferation 156 
HT HT-29 induction of cell growth arrest, induction of 
apoptosis, prolonged stress of the endoplasmic 
reticulum (ER), activation of UPR, 
overexpression of CHOP/GADD153,  
activation of  JNK, modulation of  Akt/PKB, 
inhibition of TNFα-induced NF-kB 
157 
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GRAPHICAL ABSTRACT  
 
Extravirgin olive oil polyphenols concentrate at intestinal level and, modulating microbiota, 
oxidative status and inflammation, contribute to prevent the onset or delay the progression of 
inflammatory/degenerative diseases. 
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